A meta-analysis revealed that the expression of CLEC2D (encoding LLT1) and KLRB1 (encoding CD161) genes was positively correlated with favorable prognosis in non-small cell lung cancer (NSCLC), independent of the extent of T-cell and B-cell infiltration. Here, CLEC2D is linked to non-small cell lung carcinoma.